Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Nimodipine but Not Nifedipine Promotes Expression of Fatty Acid 2-Hydroxylase in a Surgical Stress Model Based on Neuro2a Cells.

Herzfeld E, Speh L, Strauss C, Scheller C.

Int J Mol Sci. 2017 May 3;18(5). pii: E964. doi: 10.3390/ijms18050964.

2.

Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.

Fardoun MM, Nassif J, Issa K, Baydoun E, Eid AH.

Front Pharmacol. 2016 Nov 16;7:438. eCollection 2016. Review.

3.

Optimal management of digital ulcers in systemic sclerosis.

Abraham S, Steen V.

Ther Clin Risk Manag. 2015 Jun 15;11:939-47. doi: 10.2147/TCRM.S82561. eCollection 2015. Review.

4.

Acupuncture in subjects with cold hands sensation: study protocol for a randomized controlled trial.

Seo JC, Lee HJ, Kwak MA, Park SH, Shin I, Yun WS, Park K.

Trials. 2014 Sep 4;15:348. doi: 10.1186/1745-6215-15-348.

5.

Raynaud's phenomenon (primary).

Pope J.

BMJ Clin Evid. 2013 Oct 10;2013:1119. Review.

6.

Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.

Viswanath V, Phiske MM, Gopalani VV.

Indian J Dermatol. 2013 Jul;58(4):255-68. doi: 10.4103/0019-5154.113930.

7.

Evaluation of test characteristics for outcome measures used in Raynaud's phenomenon clinical trials.

Gladue H, Maranian P, Paulus HE, Khanna D.

Arthritis Care Res (Hoboken). 2013 Apr;65(4):630-6. doi: 10.1002/acr.21858.

8.

Results of a Pilot Randomized Placebo-Controlled Trial in Primary and Secondary Raynaud's Phenomenon with St. John's Wort: Detecting Changes in Angiogenic Cytokines When RP Improves.

Malenfant D, Summers K, Seney S, McBain D, Petrlich L, Watson S, Vanderhoek L, Samadi N, Bonner A, Pope J.

ISRN Rheumatol. 2011;2011:580704. doi: 10.5402/2011/580704. Epub 2011 Sep 12.

9.

Vascular involvement in systemic sclerosis (scleroderma).

Pattanaik D, Brown M, Postlethwaite AE.

J Inflamm Res. 2011;4:105-25. doi: 10.2147/JIR.S18145. Epub 2011 Jul 26.

10.

Raynaud's phenomenon (primary).

Pope JE.

BMJ Clin Evid. 2011 Mar 14;2011. pii: 1119. Review.

11.

Advances in the treatment of Raynaud's phenomenon.

Levien TL.

Vasc Health Risk Manag. 2010 Mar 24;6:167-77. Review.

12.

Recent achievements in the management of Raynaud's phenomenon.

Baumhäkel M, Böhm M.

Vasc Health Risk Manag. 2010 Apr 15;6:207-14. Review.

13.

Loss of digits after trauma in a patient with systemic lupus erythematosus.

Villanueva H, Tijunelis M, Shapiro S, Henderson SO.

West J Emerg Med. 2008 Jan;9(1):43-5.

14.

Raynaud's phenomenon (primary).

Pope JE.

BMJ Clin Evid. 2008 Dec 16;2008. pii: 1119. Review.

Supplemental Content

Support Center